[1] Kauppila JH, Mattsson F, Brusselaers N, Lagergren J. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open 2018;8:e021495.
[2] Allum WH, Griffin SM, Watson A, Colin-Jones D, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, British Society of Gastroenterology, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23.
[3] Halpern AL, McCarter MD. Palliative Management of Gastric and Esophageal Cancer. Surg Clin North Am 2019;99:555–69.
[4] Kim KY, Tsauo J, Song HY, Kim PH, Park JH. Self-expandable metallic stent placement for the palliation of esophageal cancer. J Korean Med Sci 2017;32:1062–71.
[5] Włodarczyk JR, Kużdżał J. Stenting in Palliation of Unresectable Esophageal Cancer. World J Surg 2018;42:3988–96..
[6] Bethge N, Sommer A, Gross U, von Kleist D, Vakil N. Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest Endosc 1996;43:596–602.
[7] Nelson DB, Axelrad AM, Fleischer DE, Kozarek RA, Silvis SE, Benjamin SB, et al. Silicone-covered Wallstent prototypes for palliation of malignant esophageal obstruction and digestive-respiratory fistulas. Gastrointest Endosc 1997;45:31–7.
[8] van Boeckel PG, Siersema PD, Sturgess R, Dwyer L, Raijman I, Hirdes MM, et al. A new partially covered metal stent for palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2010;72:1269–73.
[9] Uitdehaag MJ, van Hooft JE, Verschuur EML, Repici A, Steyerberg EW, Fockens P, et al. A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2009;70:1082–9.
[10] Uitdehaag MJ, Siersema PD, Spaander MCW, Vleggaar FP, Verschuur EML, Steyerberg EW, et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc 2010;71:600–5.
[11] Siersema PD, Hop WC, van Blankenstein M, Dees J. A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointest Endosc 2000;51:139–45.
[12] Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097.
[13] Higgins J, Green S. Cochrane Handbook for Systemic Reviews of Interventions. Version 5. The Cochrane Collaboration; 2011.
[14] Higgins J, Altman D, Sterne J. Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: assessing risk of bias in included studies. Cochrane Handb. Syst. Rev. Interv. Version 5., The Cochrane Collaboration; 2011.
[15] Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 2013;66:408–14.
[16] Uesato M, Akutsu Y, Murakami K, Muto Y, Kagaya A, Nakano A, et al. Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients. Gastroenterol Res Pract 2017; 2560510.
[17] Battersby NJ, Bonney GK, Subar D, Talbot L, Decadt B, Lynch N. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series. J Surg Oncol 2012;105:60–5.
[18] Eickhoff A, Hartmann D, Jakobs R, Weickert U, Schilling D, Eickhoff JC, et al. Konsekutiver vergleich von 3 verschiedenen typen selbstexpandierender metallstents zur palliation der malignen dysphagie: Ergebnisse aus dem prospektiven Ludwigshafener Ösophagus-Stentregister. Z Gastroenterol 2005;43:1113–21.
[19] Gangloff A, Lecleire S, Di Fiore A, Huet E, Iwanicki-Caron I, Antonietti M, et al. Fully versus partially covered self-expandable metal stents in benign esophageal strictures. Dis Esophagus 2015;28:678–83.
[20] Sabharwal T, Gulati MS, Fotiadis N, Dourado R, Botha A, Mason R, et al. Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: Proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol 2008;23:723–8.
[21] Seven G, Irani S, Ross AS, Ian Gan S, Gluck M, Low D, et al. Partially versus fully covered self-expanding metal stents for benign and malignant esophageal conditions: A single center experience. Surg Endosc 2013;27:2185–92.
[22] Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001;54:145–53.
[23] Van Heel NCM, Haringsma J, Boot H, Cats A, Vanhoutvin SALW, Kuipers EJ. Comparison of 2 expandable stents for malignant esophageal disease: A randomized controlled trial. Gastrointest Endosc 2012;76:52–8.
[24] Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001;12:465–74.
[25] Wang C, Lu J, Wang Y, Li GZ, Li JLT, Chen L. NON-VASCULAR INTERVENTIONS A New Fully Covered Irradiation Stent Versus a Partially Covered Irradiation Stent for Unresectable Malignant Dysphagia : A Single-Center Experience. Cardiovasc Intervent Radiol 2019;42:1142–52.
[26] Homs MY V, Steyerberg EW, Kuipers EJ, van der Gaast A, Haringsma J, van Blankenstein M, et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004;36:880–6.
[27] Verschuur EML, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: A randomized trial. Am J Gastroenterol 2008;103:304–12.
[28] Persson J, Smedh U, Johnsson Å, Ohlin B, Sundbom M, Nilsson M, et al. Fully covered stents are similar to semi-covered stents with regard to migration in palliative treatment of malignant strictures of the esophagus and gastric cardia : results of a randomized controlled trial. Surg Endosc 2017;31:4025–33.
[29] Didden P, Reijm AN, Erler NS, Wolters LMM, Tang TJ, Ter Borg PCJ, et al. Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: A randomized trial (the COPAC study). Endoscopy 2018;50:961–71.
[30] Alonso Lárraga JO, Flores Carmona DY, Hernández Guerrero A, Ramírez Solís ME, de la Mora Levy JG, Sánchez del Monte JC. Fully covered stents versus partially covered stents for palliative treatment of esophageal cancer: Is there a difference? Rev Gastroenterol Mex 2018;83:228–33.
[31] Dakkak M, Bennett JR. A new dysphagia score with objective validation. J Clin Gastroenterol 1992;14:99–100.
[32] Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut 1982;23:1060–7.
[33] Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer 2007;43:2066–73.
[34] Repici A, Jovani M, Hassan C, Solito B, Di Mitri R, Buffoli F, et al. Management of inoperable malignant oesophageal strictures with fully covered wallflex® stent: A multicentre prospective study. Dig Liver Dis 2014;46:1093–8.
[35] Saranovic D, Djuric-Stefanovic A, Ivanovic A, Masulovic D, Pesko P. Fluoroscopically guided insertion of self-expandable metal esophageal stents for palliative treatment of patients with malignant stenosis of esophagus and cardia: comparison of uncovered and covered stent types. Dis Esophagus 2005;18:230–8.
[36] Law R, Baron TH. Choosing the Appropriate Esophageal Stent for Your Patient. Am J Gastroenterol 2016;111:1669–71.
[37] Siersema PD, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy 2003;35:79–85.
[38] Ell C, May A. Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: A critical review. Endoscopy 1997;29:392–8.
[39] Verschuur EML, Homs MY V, Steyerberg EW, Haringsma J, Wahab PJ, Kuipers EJ, et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: A prospective study in 42 patients. Gastrointest Endosc 2006;63:134–40.